RNA聚合酶1和转录释放因子抗体
规格：1mg/1ml
英文名： PTRF
别名： Cavin; MGC118550; FKSG13; OTTMUSP; polymerase I and transcript release factor; RNA polymerase I and transcript release factor; RP23-279L23.6; TTF I interacting peptide 12; 2310075E07Rik; AW
分子量： 43kDa
储存液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
克隆类型：Polyclonal
亚型：IgG
纯化方法：affinity purified by Protein A
**原：KLH conjugated synthetic peptide derived from human PTRF/RNA
交叉反应：Human, Mouse, Rat, Dog, Cow, Horse,
细胞定位：细胞核 细胞浆 细胞膜
RNA聚合酶1和转录释放因子抗体产品介绍：background: Pausing of elongation complexes is mediated by the transcription termination factor TTF-I bound to the 'Sal box' terminator downstream of the rDNA transcription unit. PTRF is a Pol I and transcript release factor for dissociation of paused ternary complexes. Function: Plays an important role in caveolae formation and organization. Required for the sequestration of mobile caveolin into immobile caveolae. Termination of transcription by RNA polymerase I involves pausing of transcription by TTF1, and the dissociation of the transcription complex, releasing pre-rRNA and RNA polymerase I from the template. PTRF is required for dissociation of the ternary transcription complex. Subunit: Interacts with RNA polymerase I and TTF1. Binds the 3' end of pre-rRNA. Interacts with transcription factor ZNF148 (By similarity). Interacts with LIPE in the adipocyte cytoplasm. Subcellular Location: Cell membrane; caveola (surface). Cell membrane.RNA聚合酶1和转录释放因子抗体 Microsome. Cytoplasm; cytosol. Mitochondrion. Nucleus. Also found in the plasma membrane, microsomal and cytosolic fractions and at a low level in the mitochondrial and nuclear fractions. Post-translational modifications: Phosphorylated. Present in active and inactive forms. Changes in phosphorylation pattern may alter activity (By similarity). Five truncated forms are found in the caveolae. These are thought to be the result of proteolysis and may be phosphorylation-dependent. DISEASE: Defects in PTRF are the cause of congenital generalized lipodystrophy type 4 (CGL4) [MIM:613327]. It is a disorder characterized by the association of congenital generalized lipodystrophy with muscular dystrophy RNA聚合酶1和转录释放因子抗体and cardiac anomalies. Congenital generalized lipodystrophy is characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. Similarity: Belongs to the PTRF/SDPR family. Database links: UniProtKB/Swiss-Prot: Q6NZI2.1 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产RNA聚合酶1和转录释放因子抗体品应用：WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
研究领域：细胞生物 **学 表观遗传学
储存条件： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
来源： Rabbit
外观： Lyophilized or Liquid